Suppr超能文献

磷脂酶A2受体(PLA2R)和血小板反应蛋白基序7A(THSD7A)相关膜性肾病的临床特征与病理:一项来自中国的单中心研究

Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China.

作者信息

Pan Yan, Chen Wei Dong, Liu Lei, Yang Huijuan, Chang Baochao, Cui Caixia

机构信息

Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.

出版信息

Immunotargets Ther. 2024 Jul 25;13:385-398. doi: 10.2147/ITT.S450413. eCollection 2024.

Abstract

OBJECTIVE

Serum-specific antibodies as a non-invasive means to effectively diagnose idiopathic membranous nephropathy and assess clinicopathology.

METHODS

Immunofluorescence of anti-PLA2R and THSD7A antibodies and kidney tissue PLA2R, THSD7A and IgG4 expression in IMN and non-IMN (2020-2021) was detected to assess the efficacy of diagnosing IMN. IMN patients were divided into two groups, anti-PLA2R antibody positive (161 cases) and negative (26 cases), and two groups, kidney tissue PLA2R (40 cases) and PLA2R+THSD7A (6 cases), to compare the clinical and pathological features, and to carry out a prognostic analysis of THSD7A-positive patients, with a focus on correlation with malignancy.

RESULTS

The positive rate of anti-PLA2R antibodies was significantly higher in IMN (P<0.05); anti-PLA2R antibodies, kidney tissue PLA2R and IgG4 and THSD7A had some diagnostic value. Anti-PLA2R antibodies correlated with proteinuria levels in IMN patients, and their levels were negatively correlated with blood albumin (r=-0.146, P=0.042); correlated with pathological stage and C3 and IgG4 immunodeposition; there was no significant difference in clinical pathology between kidney tissue THSD7A+PLA2R positive compared to kidney tissue PLA2R positive patients, but the probability of achieving complete remission was low and time longer, and no malignancy events were detected during follow-up.

CONCLUSION

Anti-PLA2R antibodies, kidney tissue PLA2R, THSD7A and IgG4 have high diagnostic efficacy for IMN; anti-PLA2R antibodies can be used as diagnostic markers to assist in the assessment of clinical and pathological features; co-expression of kidney tissue PLA2R and THSD7A is not significantly different from kidney tissue PLA2R in assessing the clinical features, pathological manifestations and prognosis, but requires long-term. However, long-term follow-up is needed to monitor the potential risk, and a larger multicentre study with long-term follow-up is expected to be conducted to comprehensively assess IMN characteristics.

摘要

目的

血清特异性抗体作为一种非侵入性手段,用于有效诊断特发性膜性肾病并评估临床病理情况。

方法

检测2020 - 2021年特发性膜性肾病(IMN)和非IMN患者抗磷脂酶A2受体(PLA2R)和血小板反应蛋白7A(THSD7A)抗体的免疫荧光以及肾组织中PLA2R、THSD7A和IgG4的表达,以评估诊断IMN的效能。将IMN患者分为抗PLA2R抗体阳性组(161例)和阴性组(26例),以及肾组织PLA2R组(40例)和PLA2R + THSD7A组(6例),比较临床和病理特征,并对THSD7A阳性患者进行预后分析,重点关注与恶性肿瘤的相关性。

结果

IMN患者中抗PLA2R抗体阳性率显著更高(P<0.05);抗PLA2R抗体、肾组织PLA2R以及IgG4和THSD7A具有一定诊断价值。抗PLA2R抗体与IMN患者蛋白尿水平相关,其水平与血白蛋白呈负相关(r = -0.146,P = 0.042);与病理分期以及C3和IgG4免疫沉积相关;肾组织THSD7A + PLA2R阳性患者与肾组织PLA2R阳性患者在临床病理方面无显著差异,但完全缓解的概率较低且时间较长,随访期间未检测到恶性肿瘤事件。

结论

抗PLA2R抗体、肾组织PLA2R、THSD7A和IgG4对IMN具有较高诊断效能;抗PLA2R抗体可作为诊断标志物辅助评估临床和病理特征;肾组织PLA2R和THSD7A共表达在评估临床特征、病理表现和预后方面与肾组织PLA2R无显著差异,但需要长期观察。然而,需要长期随访以监测潜在风险,预计将开展一项更大规模的长期随访多中心研究以全面评估IMN特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e0/11287465/872ef1db0d49/ITT-13-385-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验